​

Seaport Therapeutics Ownership | Who Owns Seaport Therapeutics?


OverviewFinancialsChart

Seaport Therapeutics Ownership Summary


Seaport Therapeutics is owned by 70.07% institutional investors, 35.06% insiders. Arch venture management is the largest institutional shareholder, holding 11.76% of SPTX shares. T. Rowe Price Health Sciences is the top mutual fund, with 2.14% of its assets in Seaport Therapeutics shares.

SPTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSeaport Therapeutics70.07%35.06%-5.12%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Arch venture management6.29M11.76%$136.60M
General atlantic6.10M11.40%$132.53M
Sofinnova investments3.56M6.66%$77.43M
Goldman sachs group2.18M4.07%$47.32M
Trv gp vi2.06M3.85%$44.77M
Canada pension plan investment board1.98M3.69%$42.91M
Fmr1.84M3.43%$37.07M
Foresite capital management vi1.78M3.32%$38.65M
Jpmorgan chase1.60M2.98%$29.84M
Price t rowe associates inc /md/1.31M2.44%$28.42M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Trv gp vi2.06M19.27%$44.77M
Arch venture management6.29M12.42%$136.60M
Foresite capital management vi1.78M6.01%$38.65M
General atlantic6.10M4.56%$132.53M
Sofinnova investments3.56M4.00%$77.43M
Siren1.10M0.52%$22.09M
Bellevue group1.10M0.50%$23.89M
Pier capital169.99K0.49%$3.69M
Braidwell lp500.00K0.40%$10.86M
Advisorshares investments94.00K0.24%$1.90M

Top Buyers

HolderShares% AssetsChange
Arch venture management6.29M12.42%6.29M
General atlantic6.10M4.56%6.10M
Sofinnova investments3.56M4.00%3.56M
Goldman sachs group2.18M0.00%2.18M
Trv gp vi2.06M19.27%2.06M

Top Sellers

HolderShares% AssetsChange
Ubs group12.46K--266.72K
Jpmorgan chase1.60M0.00%-219.24K
Abrdn267.68K0.05%-42.68K
Principal financial group377.39K0.00%-37.28K
Squarepoint ops---24.75K

New Positions

HolderShares% AssetsChangeValue
Arch venture management6.29M12.42%6.29M$136.60M
General atlantic6.10M4.56%6.10M$132.53M
Sofinnova investments3.56M4.00%3.56M$77.43M
Goldman sachs group2.18M0.00%2.18M$47.32M
Trv gp vi2.06M19.27%2.06M$44.77M

Sold Out

HolderChange
Squarepoint ops-24.75K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202655-37,506,589-70-55---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
T. Rowe Price Health Sciences1.14M2.14%-
JPMorgan Small Cap Growth A734.13K1.37%-93.85K
Jennison Health Sciences Equity438.75K0.82%438.75K
PGIM Jennison Health Sciences Z438.75K0.82%-
Vanguard Morn Total Stk Mkt Idx Investor426.37K0.80%372.00K
Vanguard MStar Total Stk Mkt Idx Invest426.37K0.80%-
Fidelity Growth Company Fund424.19K0.79%73.50K
Fidelity Growth Compy Commingled Pl S356.20K0.67%60.40K
iShares Russell 2000 ETF345.56K0.65%-
Fidelity Blue Chip Growth235.90K0.44%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 03, 2026Torres Denice-Buy$99.33K
Jun 22, 2026HOMBACH ROBERT J.-Buy$235.77K

Insider Transactions Trends


DateBuySell
2026 Q41-
2026 Q21-

SPTX Ownership FAQ


Who Owns Seaport Therapeutics?

Seaport Therapeutics shareholders are primarily institutional investors at 70.07%, followed by 35.06% insiders and -5.13% retail investors. The average institutional ownership in Seaport Therapeutics's industry, Biotech Stocks , is 385.89%, which Seaport Therapeutics falls below.

Who owns the most shares of Seaport Therapeutics?

Seaport Therapeutics’s largest shareholders are Arch venture management (6.29M shares, 11.76%), General atlantic (6.1M shares, 11.40%), and Sofinnova investments (3.56M shares, 6.66%). Together, they hold 29.82% of Seaport Therapeutics’s total shares outstanding.

Does Blackrock own Seaport Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Seaport Therapeutics.

Who is Seaport Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp vi is Seaport Therapeutics’s biggest shareholder by percentage of total assets invested, with 19.27% of its assets in 2.06M Seaport Therapeutics shares, valued at 44.77M$.

Who is the top mutual fund holder of Seaport Therapeutics shares?

T. Rowe Price Health Sciences is the top mutual fund holder of Seaport Therapeutics shares, with 2.14% of its total shares outstanding invested in 1.14M Seaport Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools